Form 4: Celldex Therapeutics Executive Exercises Options and Sells Shares
SEC Form 4
Elizabeth Crowley, SR. VP & CPDO of Celldex Therapeutics, exercised stock options and sold shares on May 30, 2024.
Summary
- On May 30, 2024, Elizabeth Crowley, SR. VP & CPDO of Celldex Therapeutics, exercised incentive stock options to acquire 34,445 shares at $2.78 and 8,500 shares at $9.0165.
- She then sold 38,597 shares of common stock at a weighted average price of $33.6395, with prices ranging from $33.39 to $33.8934 per share.
- Following these transactions, Crowley directly owns 9,074 shares of Celldex Therapeutics common stock and holds options to purchase 7,500 shares.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of insider trading activity. It doesn't inherently indicate positive or negative sentiment about the company's prospects.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions, providing transparency to the market regarding the trading activities of company executives. It's common for executives to exercise stock options and sell a portion of the acquired shares for personal financial management.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the increased number of shares in the market, but the effect is likely minimal given the relatively small volume of shares involved.
Key Dates
| Date | Description |
|---|---|
| 06/13/2022 | Date the option for 8,500 shares was fully vested. |
| 06/19/2023 | Date the option for 34,445 shares was fully vested. |
| 05/30/2024 | Date of the transactions: option exercise and share sale. |
| 06/03/2024 | Date of the signature on the Form 4 filing. |
| 06/13/2028 | Expiration date of the incentive stock option for 8,500 shares. |
| 06/19/2029 | Expiration date of the incentive stock option for 34,445 shares. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.